Phil

Technology-driven hub simplifying medication access and improving patient outcomes

placeSan Francisco, California, United States calendar_todayFounded 2015 groups99 employees language phil.us

Registered entities

Reputation

Customer rating 4.8 / 5 across 20,410 reviews.

Web presence

Audience by country — top 5 markets by share of visits.

CountryShare
United States98%
India1.1%
Bangladesh0.7%
United Kingdom0.1%
Mexico0%

Social engagement

Social engagement: 31.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include GreatPoint Ventures, Crosslink Capital, Warburg Pincus.

Investor typeCountShare
Venture capital1165%
Private equity318%
Accelerator & incubator16%
Bank & private debt16%
Other / undisclosed16%

Share of voice

Share of voice in United States: 84.4% of web traffic across its competitive set; worldwide: 83.9%.

Recent activity

16 Apr 2026
Partnership
Digital Medicine Society (DiMe) and their lineup of pharma leaders
2 Apr 2026
Partnership
Tenpoint Therapeutics
16 Mar 2026
Event
Informa's AccessUSA conference
Coming soon